Mixed-lineage leukemia (MLL) fusion proteins are associated with a unique class of leukemia that is characterized by the simultaneous expression of lymphoid-specific as well as myeloid-specific genes. Here we report the first experimental model of MLL. Murine bone marrow cells were retrovirally transduced to express the MLL-eleven nineteen leukemia (MLL-ENL) fusion protein. When cultivated in flt-3 ligand, stem cell factor and interleukin-7 (IL-7) in a stroma-free culture system MLL-ENL-transduced as well as control cells showed a wave of B-lymphopoiesis. Whereas the controls exhausted their proliferative capacity in a CD19+/B220+ state, a continuously proliferating CD19À/B220+ cell population emerged in the MLL-ENL-transduced cultures. Despite the lymphoid surface marker, these cells were of monocytoid morphology. The immortalized cells contained unrearranged retrovirus, expressed MLL-ENL mRNA and were able to grow in syngenic recipients. From the diseased animals an MLL-ENL positive, B220+/CD19-cell type could be reisolated and cultivated in vitro. In analogy to human MLL, MLL-ENL-transformed cells not only coexpressed lymphocyte-specific (rag1, rag2, pax5, Tdt) and monocyte-specific genes (lysozyme, c-fms), but also showed rearrangements of the genomic immunoglobulin locus. This model shows that MLL-ENL influences events of early lineage determination and it will enable the investigation of the underlying molecular processes.
Introduction
Translocations that affect the mixed-lineage leukemia gene (MLL, alternative names are HRX and ALL1) on chromosomal segment 11q23 occur in a subset of human acute leukemias with dismal prognosis (Dimartino and Cleary, 1999; Ayton and Cleary, 2001) . In general, 11q23 aberrations can be found in myeloid as well as lymphoid leukemias, but especially the latter ones have drawn intense interest because of their unique features. The lymphatic type of MLL-translocation-bearing leukemias mainly presents itself during the first year of life and unlike other leukemias in infants an early relapse after chemotherapy is almost certain reducing 5-year survival to around 20% (Behm et al., 1996) .
The affected cells are morphologically lymphoblastic (hence the initial classification as ALL), but they are distinguished by a frequent lack of the early B-cell antigen CD10 and coexpression of the myeloid antigens CD15 and CD65 (Pui et al., 1991) . Most importantly two recent studies comparing the gene expression profiles of 'MLL'-type ALL with conventional forms of ALL and acute myeloid leukemia (AML) clearly defined this leukemia as a unique and independent new entity (Armstrong et al., 2002; Yeoh et al., 2002) . A principal component analysis of the mRNA inventory of MLL showed it to be equidistant from common ALL as well as from AML. Special hallmarks were the coexpression of myeloid and lymphoid genes and an overall expression signature that characterizes early precursor cells. Therefore, a special classification as MLL was proposed for this new disease type.
On a molecular level, 11q23 translocations always join 5 0 -terminal portions of the MLL gene to a large variety of different partners. Of these, 27 are cloned up to date with still more identified only cytogenetically (Huret et al., 2001) . The nature of the fusion partner seems to determine a bias for the generation of the myeloid versus the mixed-lineage type of leukemia, but the unifying theme of all MLL fusion genes is that they lead to the expression of a corresponding fusion protein where the modification of MLL by the fusion partner creates an active oncoprotein.
MLL has structural and functional homologies to Trithorax (TRX) of Drosophila melanogaster (Zieminvan der Poel et al., 1991; Djabali et al., 1992; Gu et al., 1992; Tkachuk et al., 1992) . Like TRX, MLL is a principal constituent of the cellular memory system that helps to maintain a pre-established transcriptional pattern. Both proteins act positively on the transcription of their target genes through changes in the chromatin structure of the respective promoter regions (Mahmoudi and Verrijzer, 2001) . In knockout experiments, the clustered homeobox (Hox) genes have been identified as targets of mammalian MLL and these studies too demonstrated a requirement for unperturbed MLL function during normal hematopoietic development (Yu et al., 1995 (Yu et al., , 1998 Hess et al., 1997; Hanson et al., 1999; Yagi et al., 1998) .
To elucidate the oncogenic principle embodied by the MLL fusion proteins, different approaches have been tried to create a mouse model of MLL. MLL fusion genes have been recreated by a genomic knockin (Corral et al., 1996; Dobson et al., 1999 Dobson et al., , 2000 and several MLL fusion proteins were introduced into the hematopoietic system by retroviral transduction (Lavau et al., 1997; Slany et al., 1998; DiMartino et al., 2000; Lavau et al., 2000a, b) . All studies unambiguously demonstrated active transforming properties of the respective fusions with essential functions contributed by both partners. However, up to date all published efforts only succeeded in mimicking the common myeloid type of MLLassociated leukemia with the more interesting and clinically relevant mixed-lineage phenotype not accessible by these approaches.
Here, we report a model of a mixed-lineage-type leukemia based on the retroviral expression of a fusion between MLL and the eleven nineteen leukemia protein (ENL). The MLL-ENL fusion protein is derived from the translocation (11;19) and constitutes one of the three most frequently found fusions in leukemia cases with an involvement of MLL. In contrast to the other two more common translocations MLL-AF9 [t(9;11)] and MLL-AF4 [t(4;11)] that are predominantly associated with either a myeloid or a lymphoid/mixed-lineage phenotype, MLL-ENL is found equally likely in both leukemic subclasses. When MLL-ENL transduced primary hematopoietic cells were cultivated under lymphoid growth conditions, a lymphoid/monocytoid biphenotypic cell was generated that was reminiscent of MLL cells. This model might thus open new avenues for the study of this important disease.
Results

Expression of MLL-ENL during lymphoid development immortalizes a B220+/CD19À cell
To investigate the consequences of the presence of MLL-ENL for lymphoid development, we applied an in vitro B-cell differentiation system that works in defined cytokine conditions in methylcellulose medium. This system allows the generation of a B220+/CD19+ pro-B-cell population that is also partially positive for cytoplasmic immunoglobulin heavy chain. To this end, primary bone marrow cells (BMCs) enriched for hematopoietic precursors by 5-fluorouracil treatment were retrovirally transduced with a pMSCV expression vector containing the MLL-ENL cDNA (pMSCVneo-MLLENL). As a control, a similar transduction was performed with empty vector (pMSCVneo). After spinoculation with virus supernatant, the BMCs were plated under drug selection in methylcellulose medium containing recombinant human flt3 ligand, mouse IL-7, and mouse stem cell factor. Preliminary experiments had shown that the presence of all three of these cytokines is necessary for efficient lymphopoiesis (not shown). The cultivation in methocel inhibited the generation of a stroma cell-layer derived from bone marrow. Stroma cells are able to support long-term B lymphopoiesis from normal bone marrow precursors ('Whitlock-Witte culture') and therefore were likely to obscure differences in the B-cell differentiation of MLL-ENL-transduced versus normal cells. Arising colonies were replated every 6-8 days in methocel for a total of four rounds. All subsequent culturing was done in liquid medium in the same cytokine conditions. Aliquots were withdrawn after each plating round and then in regular intervals from the liquid cultures and analysed for the expression of key B-cell markers.
Both MLL-ENL-transduced and neo-control cells developed into B220+/CD19+ double positive B cells within approximately 3-4 weeks. In this early phase of differentiation, the only discernible difference between MLL-ENL and neo-cells was a slower course of maturation for the former. MLL-ENL-transduced cells took 2-3 days longer to reach the same developmental state than the controls (Figure 1a ). Despite this delay, cytoplasmic m-heavy chain could be eventually detected in a fraction of both populations underscoring their Bcell identity (Figure 1a, inset) .
After approximately 4 weeks, a significant divergence of further cell development was visible in the two cultures. Whereas neo-control cells slowly exhausted their replicative capacity, MLL-ENL-expressing cells continued to proliferate vigorously (Figure 1b ). This phenomenon was accompanied by the emergence of B220+/CD19À cells that ultimately dominated the remaining population (Figure 1a , 39-day and 48-day panel). In parallel, a new and morphologically distinct cell type appeared in the MLL-ENL cultures. Next to clearly lymphoid-like cells that were prevailing (>90%) during the first weeks of differentiation (Figure 1c, upper panel) , larger cells with a higher cytoplasma/ nucleus ratio and an indented nuclear shape became visible in the later stages till 50 days post-transduction approximately 80710% of all cells showed this myeloid-like phenotype. Furthermore, the growth factor profile necessary for optimal proliferation changed during the course of the experiment (Figure 1d ). To achieve the highest growth rates, a combination of flt3 ligand, SCF, and IL-7 was necessary in the initial phase after transduction. Cultures in later stages required up to 10 times less IL-7 to reach comparable doubling rates. The transduction experiment and the associated characterization of the cells were conducted three times with essentially the same outcome. The only difference between independent experiments was a variation in time till the appearance of the B220+/CD19À population (35710 days post-transduction). Figure 1 shows one representative experiment.
The presence of nonrearranged retrovirus and of MLL-ENL-specific transcripts was verified by Southern blot and reverse transcriptase-polymerase chain rection (RT-PCR) experiments. Genomic DNA and total RNA were isolated from two separately obtained B220+/ CD19À cell populations. Hybridization of the digested DNA with a human MLL-specific probe revealed multiple integrations (BamHI digest, Figure 2a , left panel) of a full-length retrovirus (NheI digest, Figure 2a , right panel). Messenger RNA coding for MLL-ENL was detected by amplification of a diagnostic DNA fragment spanning the breakpoint between MLL and ENL with a cDNA template reverse transcribed from the isolated RNA (Figure 2b, upper panel) . In addition, the MLL-ENL retroviral construct was checked for the capacity to direct the synthesis of the corresponding fusion protein in the phoenix-E packaging cells ( Figure 2b , lower panel). To this end, nuclear extracts of transfected and mock-treated packaging cells were immunoblotted with an anti-MLL antibody. An MLL reactive protein was visible at the expected size only in the transfected cells.
To clarify which of the two subpopulations, B220+/CD19+ or B220+/CD19À, was responsible for the ongoing proliferative capacity, the cells The cells were seeded in a medium containing a fixed concentration of two cytokines (10 ng/ml for flt3 ligand and IL-7, 100 ng/ml for SCF) with the concentration of the third growth factor varying as indicated. The 3-day proliferative response was determined by a colorimetric method relying on the conversion of the formazan dye MTT by living cells to a product that absorbs light at 550 nm wavelengths. Tests were done 19 and 48 dptr. Symbols used are: blue diamonds, flt3 ligand; orange triangles, SCF; red squares, IL-7. The values represent the means 7 s.d. of triplicate experiments were sorted according to CD19 expression. Upon replating in methocel medium, only the CD19-cells did form colonies (Figure 2c ) and only these cells could be expanded further in liquid medium (not shown).
B220+/CD 19À cells grow in syngenic animals
The oncogenic capacity of the MLL-ENL-transduced cells was tested by retransplantation in syngenic recipients. For this purpose, 1 Â 10 6 sorted B220+/ CD19-cells each were injected into two Balb/C recipients that had been conditioned with busulfan 24 h before the transplantation procedure. As control, two similarly treated mice received a graft of 1 Â 10 6 neo-transduced cells in the corresponding B220+/CD19+ stage.
In contrast to the control animals that survived without any sign of disease 250 days until the termination of the experiment, the first mouse receiving a B220+/CD19À graft died 85 days post-transplantation. A post-mortem analysis revealed massive splenomegaly (spleen weight 480 mg) as well as enlarged inguinal lymph nodes and a grossly overgrown thymus that filled almost the whole chest cavity. In DNA isolated from the spleen, a prominent band corresponding to the MLL-ENL retroviral insertion could be detected by Southern blot (not shown) suggesting that the originally injected cells made a major contribution to the tumor. The second animal was killed on day 97 after transplant with advanced signs of disease (hunched posture, ruffled fur, and labored breathing). The internal anatomical aspect was identical to the first recipient (spleen weight 490 mg).
From the spleen of this animal, a cell population was established that could be continuously propagated in liquid medium. In cytospins stained with May-Gru¨n-wald-Giemsa, these cells displayed a uniform monocytoid-like morphology (Figure 3a) . Despite the myeloid appearance, all cells were positive for the B220 lymphoid surface marker and a minor proportion also stained with antibodies against c-kit and CD11b (Figure 3b ). All other tested lineage markers (CD3, Gr-1, Terl19) were negative. The cells still expressed MLL-ENL-specific message as detectable by RT-PCR and MLL-ENL DNA sequences could be amplified from DNA (Figure 3c ). Although initially established in a combination of flt3 ligand, SCF, and IL-7 these cells could survive without cytokines in the medium and were stimulated to proliferate optimally by any combination of two out of these three cytokines (not shown).
MLL-ENL-expressing lymphoid/myeloid cells combine properties of both lineages
To learn more about the nature of the MLL-ENLtransduced cells, the expression of a panel of genes normally specific for either the lymphoid or the myeloid lineage was examined by RT-PCR. RNA was isolated from the CD19+ and CD19À subpopulation after sorting of late-stage transduced cells and from cells recovered from a leukemic animal. RNA from the mouse Ml cell line served as a myeloid-specific control (Figure 4a ). Regardless of their CD19 state, all cell populations from the transduction experiments coexpressed the lymphoid-specific rag1, rag2, pax5, and TdT genes together with the genes for the myeloid markers RT-PCR analysis detecting MLL-ENL-specific fusion RNA with a breakpoint-spanning primer pair. RNA was isolated from two MLL-ENL-transduced cell populations and subjected to PCR after cDNA synthesis in the presence of RT or after a mock reaction without enzyme (as indicated). A PCR control with retroviral MLL-ENL plasmid as a control, as well as a water control are included on the same gel. The molecular weight marker used is a 1 kb ladder. Lower panel: Western blot of nuclear extracts of Phoenix packaging cells transfected with either the MLL-ENL construct or mock-transfected (cont). Proteins were detected with an anti-MLL antibody (Butler et al., 1997) . The MLL-ENLspecific band is labeled. (c) Plating efficiency of CD19À versus CD19+ cells. An MLL-ENL-transduced cell population at 40 dptr was separated into CD19+ and CD19À subpopulations by FACS sorting and the quality of the sort was assessed by subsequent reanalysis for CD 19. A total of 1000 cells of the two populations each were seeded in 1 ml methocel in standard cytokine conditions. Developing colonies were stained and photographed. The figure shows one representative well of a 24-well tissue culture plate for each sample c-fms and lysozyme. A similar expression profile was detected in the cells reisolated from the leukemic mouse with the exception that c-fms message was absent and the level of TdT transcripts was significantly lower. In the Ml myeloid control no significant lymphocytespecific gene expression was seen. Figure 4 specifically shows the results from the transduced cells that were injected into the animals.
Since the hallmark of B-lymphoid development is a rearrangement of the immunoglobulin locus, the current configuration of the respective genomic sequence was examined by a multiplex PCR strategy. DNA was isolated from the tester populations including tail tissue DNA as germ line control and DNA from the B-cell line J558L as sample for a clonal cell line with a particular Ig locus rearrangement (Figure 4b ). PCR products indicative for recombined DJ segments were found for all MLL-ENL-transduced populations. As expected, the B220+/CD19+ population showed a more advanced recombination process, whereas a significant portion of the B220+/CD19À cells still was in germ line configuration. Figure 4 depicts an example for the cell population injected into mice. A PCR band indicative for a DJ H 2 rearrangement was dominant among the amplification products using DNA from cells recovered from the leukemic animal as template. Cloning and sequencing of the respective DNA fragment showed that 5/5 examined clones had an identical sequence and were therefore likely of clonal origin (not shown).
Discussion
Here, we report the ability of the oncoprotein MLL-ENL to transform a biphenotypic lymphoid/monocytoid cell type that is reminiscent of human MLL. A recent gene profiling study of human MLL demonstrated the relative underexpression of early pro-B and pre-B-cell markers like CD22, CD24, and CD10 in MLL compared to other ALLs without participation of the 11q23 locus (Armstrong et al., 2002) . Concomitantly, genes specific for stem cells, like AC133 and also genes normally found only in the myeloid lineage, for example, AML1 were over-represented. In summary, human MLL seems either to affect a common precursor of a not yet separated B-cell/monocytic lineage or alternatively it is caused by a transdifferentiation event of an early B cell.
Also, the mouse cells transduced by MLL-ENL stop B-cell development at the beginning of the pro-B phase. DJ H rearrangement is already initiated and one of the key transcripts defining B-cell identity, pax5, is present. The Pax5 protein acts as a transcriptional regulator that RNA was isolated from the population and reverse transcribed either in the presence of reverse transcriptase or in a mock reaction. cDNA and samples of genomic DNA served as a template for an MLL-ENL-specific PCR with breakpoint-spanning primers. As a control a plasmid template was amplified activates the genes for several B-specific products and one of the major targets is the CD19 surface protein (Nutt et al., 1998) . MLL-ENL-transduced cells are pax5 positive but remain CD19 negative suggesting that MLL-ENL is able to counteract Pax5 activity at least for one of its known targets. Hematopoietic cells that have lost Pax5 by a gene knockout, however, show an unprecedented plasticity in development and can transdifferentiate into all cell lineages including erythrocytes, macrophages, granulocytes, osteoclasts, dendritic cells, and T cells (Nutt et al., 1999 (Nutt et al., , 2001 . The stage of B-cell development at which Pax5 becomes essential probably marks a decisive time point that separates earlier differentiation states with remaining plasticity from truly lineage committed cells. Any mechanism blocking maturation beyond that point might cause the outgrowth of cells with bi/multipotential behavior. In this context, it is important to note that Pax5 interacts with corepressors of the Groucho family leading to repression of genes that would initiate alternative lineage decisions (Eberhard et al., 2000) . The oncogenic fusion of MLL with ENL, however, creates a novel transcriptional activator (Schreiner et al., 1999) , thus purporting a potential point of interference with the natural processes of lymphoid lineage determination.
A small population of bipotent cells with combined Blymphoid/monocytic properties has also been identified in normal mouse bone marrow and in fetal liver (Cumano et al., 1992; Montecino-Rodriguez et al., 2001) . Interestingly, this particular cell type required flt3 ligand (Dannaeus et al., 1999) , the same growth factor that was absolutely essential to initiate the development of the biphenotypic MLL-ENL cell described here. A high level of flt3 message also was the most significant predictor for the presence of human MLL (Armstrong et al., 2002) , indicating a central role for this cytokine in the etiology of MLL-related transformation. Since a constitutively active flt3 signaling pathway caused by internal duplications of the flt3-receptor is also one of the most frequently found cooperating mutations in AML (Kelly et al., 2002; Kottaridis et al., 2001) , this molecule mandates heightened attention as a target for therapeutical approaches.
A second shared feature between the mouse and human examples of MLL is the involvement of Figure 4 Typical example of lineage-specific gene expression and Ig locus rearrangements in MLL-ENL-transduced cells. This figure shows results for the cell population that was used for transplantation. (a) RNA was isolated and cDNA was generated from sorted CD19+ and CD19Àsubpopulations as shown in Figure 2 , as well as from leukemic cells reisolated from the spleen of a transplanted mouse and the mouse Ml cell line as control. RNA integrity was tested by an actin-specific RT-PCR. A minus reverse transcriptase control is included in the upper right panel. The specificities of the primers applied are indicated beneath the respective panels. All primers except those amplifying rag1 and rag2 were designed to span introns in the corresponding gene. The spurious detection of rag1 and rag2 amplification products in the Ml myeloid control line is probably because of residual DNA contamination. All PCR reactions were done with 30 amplification cycles except for the actin-specific reaction (upper left panel) that was cycled 25 times. (b) Multiplex PCR detecting DJ H rearrangements in the genomic Ig locus. Chromosomal DNA was isolated from the same cell types as in 'A'. Tail DNA served as a germ line configuration control and DNA from the plasma cell line J558L was a positive control for rearrangement. The PCR strategy utilizing two degenerate upstream primers in combination with a common downstream anchor primer is depicted schematically secondary mutations. As visible from the DJ H rearrangements, a subclone of the originally injected cell population became dominant during passage in the animal. Furthermore, the reisolated cells did not rely any more on cytokines for survival and displayed only a relaxed requirement for growth factors to proliferate. Many human MLL cell lines are completely factor independent and can be cultivated with fetal calf serum (FCS) as the sole growth stimulant, a hint for potential autostimulatory processes. The striking prevalence of high levels of flt3 messenger RNA in human MLL might represent a sign for an acquired mutation on a path to autocrine growth support.
Interestingly, in a similar experimental approach it has been shown that the same MLL-ENL oncoprotein could also elicit an exclusively myeloid type of leukemia. MLL-ENL-transformed myeloid cells were reversibly arrested in an early state of development, could be forced into terminal differentiation by the addition of maturation promoting cytokines, and appeared to have acquired cooperating mutations (Lavau et al., 1997; Schreiner et al., 2001) . The major difference between these experiments and the strategy described here was the initial cytokine environment used to propagate the MLL-ENL-transduced cells. This supports the role of MLL-ENL as an universal inhibitor of hematopoietic differentiation that blocks a common early-maturation step. Additional input signals from growth factors then seem to modulate the final phenotypic appearance of the transformed cells. The observation that some of the MLL fusion proteins are preferentially associated with one of the two leukemia subtypes could therefore be because of a bias in their influence on cytokine production or a change in the sensitivity to cytokine signaling. Models like the one described here will open the way for further research to find ways of intervention for treatment of MLL-associated leukemias.
Materials and methods
Tissue culture, media, supplements, and growth factors All bone-marrow-derived cells were kept in RPMI1640 supplemented with 10% prescreened FCS, 100 U/ml penicillin/streptomycin, and appropriate growth factors. Phoenix packaging cells were cultivated in DMEM (4500 mg/ml glucose)/10% FCS with penicillin/streptomycin. All cells were incubated under normal pO 2 in humidified incubators at 371C.
If not stated otherwise growth factors were used at the following concentrations: recombinant murine SCF: 100 ng/ ml; recombinant murine IL-7: 10 ng/ml; recombinant human flt3 ligand 10 ng/ml. Media for cultivation of lymphoid cells contained 100 mm -mercaptoethanol. Media were purchased from Life Technologies (Karlsruhe, Germany) and cytokines were from Strathmann Biotech (Hannover, Germany). For plating in methylcellulose Methocult 3234 from Stem Cell Technologies was used (Vancouver, Canada).
Retroviral transduction of mouse primary hematopoietic cells
High titer retrovirus supernatants were produced in the ecotropic packaging cell line Phoenix-E by calcium-phosphate transfection with a previously described pMSCV-based retroviral vector containing the MLL-ENL cDNA (pMSCVneo-MLLENL) (Slany et al., 1998 ). An empty vector without insert served as a control. Phoenix-E cells were obtained from Gary Nolan (Stanford, CA, USA) and maintained as outlined on the world wide web under: http://www.stanford.edu/group/ nolan. The transient transfection procedure routinely yielded viral titers in the range 5 Â 10
6 CFU/ml when tested on NIH3T3 cells.
The retroviral transduction of primary hematopoietic cells was done according to Lavau et al. (1997) . In short, BMCs enriched in noncycling hematopoietic precursors were recovered from femurs and tibias of Balb/C mice that had been primed 5 days previously with an i.p. injection of 150 mg/kg 5-fluorouracil (10 mg/ml in PBS). Prior to infection, the BMCs were activated in 96-well V-shaped microtiter plates for 24 h by a cytokine cocktail (10 ng/ml, IL-3; 10 ng/ml, IL-6; 100 ng/ml, SCF) in a medium containing 100 mm b-mercaptoethanol. After infection by spinoculation (3 h, 351C, 2500 xg) in the presence of 4 mg/ml polybrene, the treated cells were returned to activation medium as above. Following overnight incubation, duplicates of 2 Â 10 4 infected cells each were plated in 24-well plates under G418 drug selection (1 mg/ml) in 1ml of MethoCult murine methylcellulose medium with the addition of 100 ng/ml SCF, 10 ng/ml IL-7, and 10 ng/ml flt3 ligand. Colonies emerging after 6-7 days were recovered from the methocel medium, analysed by FACS, and 2 Â l0 4 cells were replated under identical conditions with the exception that drug selection was omitted in subsequent rounds. After four courses of replating, the cells were cultivated in liquid medium in the same cytokine cocktail.
FACS analysis and sorting
Surface marker expression was determined with FITC-or PEconjugated antibodies (Becton Dickinson, Pharmingen, USA) specific for B220, CD19, CD3, Gr-1, CD11b, and Terl19 according to the instructions of the manufacturer. Intracellular IgM was detected with an FITC-conjugated rabbit anti-mouse IgM (Sigma, Taufkirchen, Germany) after permeabilization of the cells with Leucoperm reagent (Serotec, UK) as recommended. Cell sorting was done on a MoFlow high-speed cellsorting machine.
Growth assessment
For proliferation measurements either the absolute cell numbers were determined by direct counting after Trypan blue staining, or growth rates were determined by the colorimetric MTT test. For this purpose, cells were seeded in triplicates in 96-well plates in 100 ml of appropriate growth medium. After the intended incubation period, 10 ml of a 5 mg/ml solution of (3-[4,5-dimethyltriazol-2-yl]-2,5-diphenyl tetrazolium bromide) (MTT) was added and the cells incubated for further 4 h. MTT is converted by living cells to an insoluble formazan salt that can be solubilized by the addition of 100 ml of 10% SDS, and 0.01 M HCl solution, and photometrically determined at 550 nm wavelength.
Bone marrow transplantation
For transplantation of transduced BMCs, mice were conditioned by a single i.p. injection of 25 mg/kg busulfan as a 5 mg/ ml suspension in sterile corn oil; 24 h after this treatment 1 Â 10 6 transduced cells in PBS were injected intraperitoneally. The mice were fed with autoclaved chow and supplied with drinking water containing 1.1 g/L neomycin sulfate and 10 6 U/ L polymixinB sulfate in individually vented cage systems. The appropriate Institutional Review boards approved all animal procedures.
RT-PCR, Southern blot
Total RNA was isolated by ion-exchange chromatography with kits from Qiagen (Hilden, Germany) according to the recommended protocols. DNA impurities were removed by the DNAfree reagent system (Ambion, Austin, TX, USA) as recommended. Specific RNAs were detected by RT-PCR after reverse transcription of total RNA with random hexamer primers (30 cycles: 941C, 30 s; 651C 30 s; 721C, 30 s; except for the actin-specific PCR that was amplified with 25 cycles). For detection of the MLL-ENL fusion transcript, the primers for amplification were designed to span the breakpoint between the fusion partners: MLL common primer: gcaaacagaaaaaagtggctccccg; ENL reverse primer: tcatgtggccacggcctccag. Primers for amplification of actin: cctgggcatggagtcctg and ggagcaatgatcttgagcttc. Other primers used were: raglforward: tgcagacattctagcactctgg; raglreverse: acatctgccttcacgtcgat; rag2-forward: cttctctagagattcctgctacctcccacc; rag2reverse: tctggaattcactgctggggtacccagggg; pax5 forward: agatgtagtccg ccaaaggatagt; pax5reverse: agtgtcattgtcacagactcgctc; TdT forward: gatttctagacttggtcctcttcattttgg; TdTreverse: caaggaattccctctgtgtctttcatgctg; c-fmsforward: gagtcagaagcccttcgacaaa; c-fmsreverse: tgcccagaccaaaggctgtagc; lysozyme forward: ggatgacatcactgcagccatac; lysozyme reverse: gtctgtgtggtgatcattgtgttg; DJ H rearrangements in the Ig Locus were detected by a PCR strategy employing two upstream degenerate primers binding 5 0 of the DFL/DSP element (acgtcgacttttgtsaagggatctactactgt) or the DQ52 element, respectively (acgtcgacgcggassaccacagtgcaactg). The reverse primer (gggtctagactctcagccggctccctcaggg) was complementary to a binding site downstream of the J H 4 segment. All three primers were used in a single PCR reaction as outlined in Martensson et al. (1997) .
Southern blotting was done on DNA isolated by phenol/ chloroform extraction after a transfer under alkaline conditions according to standard procedures.
